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HemagglutininThe 2009 human pandemic inﬂuenza (H1N1) virus possesses the HA gene of the H1 subtype. The
evolutionary process of the 2009 H1N1 virus remains to be deﬁned. We performed genetic analyses of the
HA gene by comparing the 2009 H1N1 virus with seasonal human and swine viruses.
We analyzed sequences of 116 2009 H1N1 viruses, and obtained 1457 seasonal H1N1, 365 swine H1, and
1332 2009 H1N1 viruses from the database. Selection pressure for the 2009 H1N1 virus was higher than that
for the swine virus and equivalent to that for the seasonal virus. Positions 206 and 264 were found to be
positively selected sites. We also identiﬁed sites under different selection pressures from the seasonal or
swine virus that may be involved in imparting signiﬁcant biological characteristics.
The evolutionary characteristics of the H1 gene of the 2009 H1N1 virus differed from those of seasonal and
swine viruses.. Oshitani).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The inﬂuenza virus is a common cause of respiratory infections
worldwide. Subtypes of the inﬂuenza A virus are determined by the
antigenicity of two surface glycoproteins: hemagglutinin (HA) and
neuraminidase (NA). The H1N1 and H3N2 subtypes have been
circulating within the human population since 1977.
A pandemic occurred from 1918 to 1919 due to the Spanish
inﬂuenza (H1N1) virus, and its progeny viruseswere circulating in the
human population until 1957 (Webster et al., 1992). The H1N1 virus
disappeared in 1957 and was replaced by the H2N2 virus when the
Asian inﬂuenza (H2N2) pandemic occurred. Thereafter, the Hong
Kong inﬂuenza virus (H3N2) caused a pandemic in 1968. However,
the H1N1 virus reemerged in 1977 as the Russian inﬂuenza, which
was similar to H1N1 viruses isolated in the 1950s (Webster et al.,
1992). Since then, the progeny of the H1N1 virus has been circulating
as a seasonal virus along with the H3N2 virus. Furthermore, in April
2009, outbreaks of inﬂuenza in the human population caused by a
novel H1N1 virus that had originated from the swine inﬂuenza virus
were reported from Mexico and the US (Garten et al., 2009; Smith et
al., 2009). Reassortment between swine inﬂuenza viruses in two
distinct lineages, “triple reassortant” and “Eurasian avian-like swine,”
led to the generation of the 2009 pandemic H1N1 virus. The source of
the swine inﬂuenza virus lineage “triple reassortant” itself comprisedgenes derived from avian, human, and swine inﬂuenza virus lineages
(Garten et al., 2009; Smith et al., 2009). The novel 2009 pandemic
H1N1 virus has spreadworldwide, and theWorld Health Organization
(WHO) raised its ofﬁcial pandemic alert level to phase 6 on its six-
phase scale on June 11, 2009. According to WHO, more than 208
countries and overseas territories or communities have reported
laboratory-conﬁrmed cases of pandemic inﬂuenza, including at least
12,799 deaths, as of January 2010: http://www.who.int/csr/don/
2010_01_08/en/index.html (The World Health Organizaion, 2010).
HA protein is responsible for virus attachment, and the subsequent
fusion of viral and cellular membranes (Earp et al., 2005; Skehel and
Wiley, 2000; Steinhauer, 1999). Furthermore, HA may also play a
structural role in budding and particle formation (Earp et al., 2005;
Skehel and Wiley, 2000; Steinhauer, 1999). It is a rod-shaped
molecule with its stalk inserted into the viral membrane and
projecting like a spike. It is synthesized as a single polypeptide
chain (HA0), and the HA0 precursor cleaves into HA1 and HA2
subunits: a long ﬁbrous stem, comprised of an HA2 component, and a
globular head, comprised of an HA1 component (Gamblin et al.,
2004). The receptor binding site lies within the globular head of the
molecule (Skehel andWiley, 2000). The receptor binding speciﬁcity of
HA, which is determined by the nature of the amino acids that form
the receptor binding pocket, is responsible for the host range
restriction of the virus (Rogers and Paulson, 1983).
Antigenic drift is an accumulation of point mutations in HA or NA
genes, leading to minor and gradual antigenic changes (Webster et al.,
1992). Drift variants emerge due to positive selection of spontaneous
mutants that can evade the existing immunity. HA protein is a major
315Y. Furuse et al. / Virology 405 (2010) 314–321antigenic component of the virus. For H1 viruses, antigenic sites are
designatedasCa1, Ca2, Cb, Sa, andSb (Gerhardet al., 1981; Stevens et al.,
2004). Antigenic sites surround the sialic acid receptor binding site.
Single point mutations in an HA antigenic site can be sufﬁcient for
antigenic variation. In addition, oligosaccharide side chains to HA are
believed to facilitate viral escape from an immune response (Schulze,
1997; Wei et al., 2010). The number of N-glycosylation sequons (Asn-
Xaa-Ser/Thr, where Xaa is any amino acid except Pro) in HA sequences
has been increasing in the human population since the emergence of
Spanish inﬂuenza (Igarashi et al., 2008). From 1918 to 1957, and from
1977 to 2009, further substantial antigenic evolution of human H1N1
viruses occurred (Kilbourne et al., 2002; Tumpey et al., 2004). Antigenic
evolution of the virus was sufﬁcient to recommend eight different
strains for the H1N1 component of the inﬂuenza virus vaccine from
1977 to 2009 (Hay et al., 2001; Health Protection Agency, 2009). Based
on the theoryofnatural selection, positively selected sites inHAcouldbe
found by calculating the selection pressure (Suzuki, 2006, 2008). This
may be useful for identifying the epitopes involved in the elimination of
viruses from infected patients.
The novel 2009 pandemic H1N1 virus (from here, we refer to the
virus as “2009 H1N1 virus”) possesses the HA gene of the H1
subtype, which is also possessed by the seasonal H1N1 inﬂuenza
virus. However, the similarity of HA genes between seasonal and
2009 H1N1 viruses is only ∼73%. Therefore, the existing immunity
for the seasonal virus would not prevent infection with the 2009
H1N1 virus (Garten et al., 2009; Hancock et al., 2009; Itoh et al.,
2009). The virus has spread rapidly worldwide with substantial
morbidity and mortality rates. The mechanisms by which the 2009
H1N1 virus has evaded host range restriction are a major topic for
study (Furuse et al., 2010; Mehle and Doudna, 2009). Besides, the
evolutionary process of the 2009 H1N1 virus remains to be deﬁned
since its introduction in the human population. The virus respon-
sible for the Spanish inﬂuenza pandemic from 1918 to 1919 may
have evolved by becoming much more lethal, thereby leading to a
second wave with higher mortality (Reid et al., 2003). In addition,
inﬂuenza viruses from different hosts have evolved under different
selection pressures (Furuse et al., 2009).
Thus, genetic analysis comparing 2009 H1N1 as well as seasonal
human and swine viruses should provide a critical insight into the
evolutionary course and mechanisms of the inﬂuenza virus. It would
be intriguing to know whether or not seasonal (progeny of Spanish
inﬂuenza virus) and 2009 H1N1 viruses are under different selection
pressures in the same human population, and whether or not 2009
H1N1 and swine viruses are under different selection pressures, since
the 2009 H1N1 virus was derived from the swine virus.
In this study, we performed phylogenetic analyses of the H1 subtype
HA gene and showed the difference and similarity in evolutionary
characteristics among seasonal H1N1, swine H1, and 2009 H1N1 viruses.
Results and discussion
We calculated the evolutionary rates of and selection pressures on
the entire HA gene of seasonal H1N1, swine H1, and 2009 H1N1
viruses. The evolutionary rate is described by the number of
substitutions/site/year. A higher selection pressure indicates that
the gene or sitewas under stronger selection, i.e., positive selection for
amino acid substitution. Lower selection pressure indicates that the
gene or site was under stronger negative selection to retain the same
amino acid(s), because changesmay lead to incompetence or abortion
(Pond et al., 2007; Suzuki and Gojobori, 1999).
The evolutionary rate of seasonal H1N1 (1918–1957), seasonal
H1N1 (1977–2009), swine H1 (1930–2009), and 2009 H1N1 (March–
December 2009) viruses was 2.9×10−3, 1.7×10−3, 1.9×10−3, and
0.9×10−3 substitutions/site/year, respectively (Fig. 1). The evolu-
tionary rate of 2009 H1N1 virus wasmuch lower than that of the other
viruses. However, the evolutionary rate of 2009 H1N1 virus wasunreliable as the correlation coefﬁcient was very low (R2=0.01). We
observed the evolutionary trend of 2009 H1N1 virus for only
10 months. A longer period of observation is needed to establish the
evolutionary rate of the virus.
The selection pressure for the swine H1 virus was the lowest
among the viruses analyzed (Fig. 2). However, 2009 H1N1 virus,
which originated from the swine H1 virus, had similar or even higher
selection pressure compared with the seasonal H1N1 virus. Adapta-
tion to a new host, humans, may have increased the selection pressure
of 2009 H1N1 virus.
The antigenic evolution of swine viruses occurred more slowly
than that of human viruses, although rates of genetic evolution of the
HA genewere similar for both (de Jong et al., 2007; Sugita et al., 1991).
We also showed that the selection pressure for the swine H1 virus was
lower than that for the seasonal H1N1 virus, whereas the evolutionary
rates for swine H1 and seasonal H1N1 viruses from 1977 to 2009were
equivalent. This could be the consequence of a lower selection
pressure affecting the antigenic properties of HA in pigs. A vast
majority of domestic pigs are killed at the age of 6 months, and thus
the susceptible pig population is continuously renewed, thereby
limiting the build-up of immune pressure. Because of the short
average life span of pigs, evolution of the swine inﬂuenza virusmay be
determined only to a limited extent by the immune pressure, a driving
force for the antigenic drift of inﬂuenza viruses in humans.
Furthermore, comparison of the data for the seasonal H1N1 virus
from 1918 to 1957 and from 1977 to 2009 indicated that the
evolutionary rate and selection pressure of this virus decreased after
its reemergence in 1977. These results suggest that the seasonal H1N1
virus did not have amino acid substitutions as frequently as before,
and these results are compatible with those of previous reports
(Raymond et al., 1986; Shen et al., 2009). The virusmight already have
been well adapted to humans when it reemerged in 1977. The
selection pressure for 2009 H1N1 virus is as high as that for the
seasonal virus from 1918 to 1957. The selection pressure could be
high, especially in the early stage of viral pandemics, due to increased
adaptation to a new host.
Fig. 3 shows positively selected sites in the HA1 region. Selection
proﬁles are different among viruses. Eight positively selected sites
were identiﬁed for the seasonal H1N1 virus. Among these, sites at
positions 187, 190, 192, and 225, identiﬁed by H3 numbering, are
located at antigenic sites. Mutations in these sites could be due to
positive selection imposed by the host's immune response, leading to
antigenic drift. Besides, mutations in positions 190 and 225 are key
determinants for effective binding to human-like receptors (Kobasa et
al., 2004; Stevens et al., 2006; Tumpey et al., 2007). Mutations in these
sites might result in a change in the receptor binding afﬁnity in
humans. Due to the overlapping locations of the antigenic sites and
receptor binding sites of HA, the biological signiﬁcance ofmutations at
these sites is controversial (Shen et al., 2009). Hensley et al. recently
showed that neutralizing antibodies selected escape mutants with a
mutation in HA that increased viral binding to cell receptors (Hensley
et al., 2009).
Four sites were found to be positively selected for the swine H1
virus. Among these, positions 83 and 192 were located at antigenic
sites. Swine inﬂuenza virus is considered to be under weak selection
pressure by the host's immune system (de Jong et al., 2007), and we
showed lower selection pressure on swine H1 virus (see above).
Although the selection pressure on swine virus is weak, results
indicate that selection pressure has inﬂuenced the evolution of the
virus, leading to amino acid substitutions at antigenic sites. de Jong et
al. proved the occurrence of the antigenic evolution of swine viruses
(de Jong et al., 2007). Furthermore, no sites involved in receptor
binding speciﬁcity were under positive selection in the swine H1
virus. The receptors of swine cells can bind to both human and avian
inﬂuenza viruses, which possess both N-acetylsialic acid attached to
galactose with an α2,6 linkage (SAα2,3Gal) and SAα2,6Gal (Ito et al.,
Fig. 1. Evolutionary rate. Numbers of nucleotide substitutions compared with A/South Carolina/1/18 (H1N1) are plotted. Evolutionary rates are calculated from the slope of the
tangent of a simple regression line (number of substitutions/site/year) for seasonal H1N1 (1918–1957 and 1977–2009), swine H1, and 2009 H1N1 viruses. The square of the
correlation coefﬁcient (R2) was estimated using Pearson correlation. Expansion for 2009 H1N1 virus is also shown.
Fig. 2. Selection pressure. Selection pressures for the whole sequence (ω) are calculated
for the entire coding region of the HA gene. Error bar shows 95% conﬁdence interval.
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was not observed for sites related to receptor binding. We calculated
an average for dN/dS at sites involved in receptor binding speciﬁcity
(Fig. 3). The average for selection pressures was very low for the
swine H1 virus.
For 2009 H1N1 virus, positions 206 and 264 were found to be
positively selected sites (Fig. 3). It should be noted that no sites under
positive selection for 2009 H1N1 virus overlapped with those for the
seasonal or swine virus, i.e., sites under positive selection in 2009
H1N1 virus were not positively selected in the seasonal or swine virus.
As observed with the seasonal H1N1 virus, one of the sites under
positive selection for 2009 H1N1 virus, position 206, was involved in
antigenicity. Mutation in this site could be due to positive selection
imposed by the host's immune response. It is surprising that selection
pressure had already been imposed on 2009H1N1 virus, althoughonly
a year has passed since its introduction into the human population,
which does not possess immunity to 2009 H1N1 virus, except for
cross-reactive immunity observed in some elderly people (Garten et
al., 2009; Itoh et al., 2009). The virus must be circulating very rapidly
and extensively in the human population, evolving under positive
selection through the host's immune response. Another possibility is
that mutation at the site can be advantageous for the virus, e.g., by
increasing receptor binding afﬁnity and/or replication ability.
We also identiﬁed a site at position 264 as being positively selected
for 2009 H1N1 virus. However, its speciﬁc role is unknown.
Experimental studies are needed to clarify the signiﬁcance of this
mutation. The site may possess unknown characteristics such as being
part of unidentiﬁed antigenic sites. Furthermore, no sites involved in
receptor binding speciﬁcity were under signiﬁcant positive selection
(Fig. 3A). 2009 H1N1 virus is considered to be able to recognize
human-type receptors (Childs et al., 2009; Yang et al., 2010). Receptor
binding sites may not have to be mutated to increase adaptation in
humans. However, we identiﬁed many nonsynonymous mutations at
sites involved in receptor binding speciﬁcity, even if they were not
positively selected. Averaged selection pressure on sites involved in
receptor binding speciﬁcity for 2009 H1N1 virus was considerably
higher than that for the swine H1 virus (Fig. 3A). Matrosovich et al.
showed that the receptor binding speciﬁcity of HA is altered soon after
the transmission of an avian virus to mammalians and, therefore, maybe a prerequisite for the highly effective replication and spread that
characterizes epidemic strains (Matrosovich et al., 2000). We should
continue to monitor whether mutation at receptor binding sites can
occur, leading to changes in receptor binding speciﬁcity.
We also observed a differential in site-by-site selection pressures
between viruses. We identiﬁed and mapped sites under signiﬁcantly
different selection pressures between 2009 H1N1 and seasonal H1N1
viruses, and between 2009 H1N1 and swine H1 viruses (Fig. 4 and
Supplementary Table S1). The number of sites under higher selection
pressure in 2009 H1N1 virus compared with the seasonal H1N1 or
swine H1 virus (yellow sites in Fig. 4) was higher than the number of
sites under lower selection pressure in 2009 H1N1 virus compared
with the seasonal H1N1 or swine H1 virus (purple sites in Fig. 4).
These results are compatible with those in Fig. 3B, which shows that
2009 H1N1 virus possesses more sites at which dN/dS was N1 than
either the seasonal H1N1 or swine H1 virus. These sites may play
signiﬁcant roles in 2009 H1N1 virus. Another possibility is that their
selection pressure was overestimated. As intensive surveillance had
been conducted for 2009 H1N1 virus; incidentalmutations that would
not be maintained by purifying selection (also known as “negative
selection”) have also been found.
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in various parts of HA. They are situated at antigenic sites, receptor
binding sites, or sites whose roles are unknown. The HA gene of 2009
H1N1 virus must have evolved with several functions. Furthermore,
many sites thatwere under lower selection pressure in 2009H1N1virus
than in either the seasonal H1N1 or swine H1 virus are located at
antigenic sites (see blue sites in Fig. 4A andpurple sites in Figs. 4B andC),
and, some of these are N-glycosylation sequons in the seasonal H1N1
virus (see green sites in Fig. 4A). Additional N-glycosylations during
future antigenic changes in HA of 2009 H1N1 virus have been predicted
(Igarashi et al., 2010).Wei et al. showed that additional N-glycosylation
sequons in HA of 2009 H1N1 virus led to resistance to neutralizing
antibodies (Wei et al., 2010). However, 2009 H1N1 virus has not
acquired any additional N-glycosylation sequons since its emergence
(data not shown).
These results indicate that selection pressure at antigenic sites in
either swine or seasonal virus was not present at the same sites in
2009 H1N1 virus. Until now, immune pressure appears to have been
working at different sites for 2009 H1N1 virus and seasonal H1N1 or
swine H1 virus. Sites under lower selection pressure in 2009 H1N1
virus than in the seasonal H1N1 or swine H1 virus might also be
mutating in 2009 H1N1 virus to escape any future immune response.
There is the possibility of the existence of common epitopes for
neutralizing antibodies cross-reactive to both HAs for the pandemic
viruses of 1918 and 2009 (Igarashi et al., 2010; Yang et al., 2010). Also,
Igarashi et al. showed that early human H1N1 viruses isolated from
the 1930s to the 1940s still harbored some of the original epitopes
that are also found in 2009 H1N1 virus (Igarashi et al., 2010). We
should monitor whether mutations might occur at additional sites,
including sites positively selected in the seasonal or swine virus. If this
occurs, it would be interesting to discover whether these mutations
alter the biological characteristics of the virus.
In the present study, we included sequences both from isolates
(using cell lines or eggs) and clinical samples, or unknown origin.
Mutations can occur during isolation or passage in cell lines (Fitch et
al., 1997; Zhirnov et al., 2009). Egg-adapted inﬂuenza viruses also
have non-natural host-associated modiﬁcations in HA sequences
(Robertson et al., 1987; Shen et al., 2009). Therefore, the results of the
present study may contain some false positives. However, sites under
positive selection in 2009 H1N1 virus (positions 206 and 264) have
not been reported previously as egg-adapted mutations (Gambaryan
et al., 1999; Robertson et al., 1987; Xu et al., 1993).
Conclusions
The 2009 H1N1 virus was introduced into the human population
from the swine population. Within a year, the virus has evolved
rapidly and extensively following its emergence. In conclusion,
evolutionary characteristics of the H1 gene of 2009 H1N1 virus differ
from those of the seasonal H1N1 and swine H1 viruses. We identiﬁed
sites under positive selection and different selection pressures from
the seasonal H1N1 or swine H1 virus that may be involved in
imparting signiﬁcant biological characteristics such as antigenicity
and receptor binding speciﬁcity.
Materials and methods
Viruses and sequencing
Nasopharyngeal swabswere collected from patients with inﬂuenza-
like illnesses and who had visited pediatric clinics in Sendai City, Japan,
from September to December 2009. Clinical specimenswere inoculated
into Madin–Darby canine kidney (MDCK) cells with 3.5 μl/mL of
trypsin. Viral RNA was extracted from isolates using the RNeasy Mini
Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's
instructions. Viral RNA was reverse-transcribed into complementaryDNA using an inﬂuenza A generic primer, Uni12, as reported elsewhere
(Hoffmann et al., 2001). PCR was then performed to amplify all
segments, including the HA gene, as reported elsewhere (Inoue et al.,
2010). Templates were labeled by performing a cycle-sequencing
reaction using BigDye Terminator ver. 3.1 (Applied Biosystems, Foster
City, CA, USA), and the products were analyzed using an automatic
sequencer (3730xl Genetic Analyzer, Applied Biosystems) according to
the manufacturer's instructions. A total of 116 pandemic 2009 H1N1
viruses were analyzed (supplementary ﬁle).
Sequence data
In addition to the sequence data we analyzed for 2009 H1N1 virus,
data were also obtained from the inﬂuenza sequence database
(Inﬂuenza Virus Resource: http://www.ncbi.nlm.nih.gov/genomes/
FLU/FLU.html, accessed January 14, 2010) (Bao et al., 2008). Sequences
used were from both isolates (using MDCK cells or eggs) and clinical
samples, or unknown origin. All sequencing data for viruses with a full-
length H1 subtype HA gene of human and swine inﬂuenza A viruses
were included. Sequences derived from laboratory strains were
excluded, and 1457, 365, and 1332 sequences were obtained for
seasonal H1N1, swine H1, and 2009 H1N1 viruses, respectively
(supplementary ﬁle). Sequences containing minor insertions, minor
deletions, or untranslatable codons were excluded. A multiple align-
ment of nucleotide sequences was constructed using ClustalW.
A phylogenetic tree for the swine inﬂuenza viruswas constructed by
the neighbor-joining method using Molecular Evolutionary Genetics
Analysis (MEGA) ver. 4 (Kumar et al., 2008). Based on the tree structure,
swinevirusesof theNorthAmerican lineage, including triple reassortant
viruses from which 2009 H1N1 virus originated (Garten et al., 2009;
Smith et al., 2009), were selected for further analyses.
Evolutionary rate
The evolutionary rate of each group was calculated as follows: up to
100 sequences of each group were selected, and the evolutionary rate
was analyzed for selected sequences with a linear regression model as
the number of substitutions/site/year compared with A/South Car-
olina/1/18 (GenBank accession no. AF117241). Periods of evolutionary
rates calculatedwere40 years, 33 years, 80 years, and10 months for the
seasonal H1N1 (1918–1957), seasonal H1N1 (1977–2009), swine H1
(1930–2009), and 2009 H1N1 viruses (March–December 2009),
respectively.
All results were based on pairwise analysis, which was performed
using the Maximum Composite Likelihood method in MEGA (ver. 4).
The signiﬁcance of correlations was estimated using Pearson
correlation.
Selection pressure
Phylogenetic trees for each dataset of the host were constructed
using the maximum likelihood method implemented in PhyML-aLRT
(Anisimova and Gascuel, 2006) with the GTR model, which included
four rate categories, all parameters of which were estimated from the
data.
Positive selection siteswere detected using the ﬁxed effects likelihood
method, which is based onmaximum likelihood estimates. Relative rates
of nonsynonymous and synonymous substitutions (dN/dS) in each codon
were compared. Sites where dN/dSN1 and dN/dSb1 were inferred as
positively and negatively selected, respectively. Furthermore, global
estimates, ω, of dN and dS, averaged over the entire alignment, were
compared to calculate the overall strength of selection (Pond et al., 2007).
Details of the method are described elsewhere (Campo et al., 2008;
Kosakovsky Pond and Frost, 2005; Pond et al., 2007). The differential of
evolutionary pressure was also analyzed by HyPhy, which tests the
hypothesis as to whether dN/dS at a given site differs between two
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Fig. 4. Sites under different selection pressures. A) Antigenic structure of HA. Antigenic sites are shaded in blue, sites involved in receptor binding speciﬁcity are in red, N-glycosylation
sequons of Spanish inﬂuenza and 2009 H1N1 viruses are in light green, and additional N-glycosylation sequons of the seasonal H1N1 virus are in green. Sites selected positively in 2009
H1N1 virus are indicated by circles. B) Sites under different selection pressure between 2009 H1N1 and seasonal H1N1 viruses. Sites shaded yellowwere under higher selection pressure
in 2009 H1N1 virus, and those shaded purple were under lower selection pressure. C) Sites under different selection pressure between 2009 H1N1 and swine H1 viruses. Sites shaded
yellow were under higher selection pressure in 2009 H1N1 virus and those shaded purple were under lower selection pressure.
319Y. Furuse et al. / Virology 405 (2010) 314–321datasets along the phylogenetic tree. Details are described elsewhere
(Pond et al., 2006, 2007).
3D structures are shown as a solvent-accessible surface represen-
tation prepared from A/swine/St-Hyacinthe/148/1990 (H1N1) (PDB
ID 1RUY) by PyMOL (Gamblin et al., 2004). Sites were numberedFig. 3. Selection proﬁle. A) List of sites under positive selection. The signiﬁcance of ﬁxed effec
denominator=0. *The site does not possessH3numbering. **Average of selection pressures on
abscissa indicates the codon position. The ordinate indicates the 1−P value for each position, a
horizontal lines represent 0.95 so thatpositionswherebars cross the lines above indicate positiv
H3 and H1 numbering.based on H1 and H3 numbering. H1 numbering was performed by
counting from the initiation codon to the termination codon based on
A/South Carolina/1/18 (H1N1). H3 numbering was performed by
separately counting HA1 and HA2 regions (Nobusawa et al., 1991;
Stevens et al., 2004). Antigenic sites for H1 and positions of aminot likelihood (FEL) results for positive selection levels is given as a P value. inf, inﬁnity as
sites involved in receptor binding speciﬁcity. B) Selection proﬁle for each codonofHA1. The
nd is above or below the horizontal line, respectively, when dN/dSN1 or dN/dSb1. Upper
ely selected sites. Positively selected sites are indicatedbyarrowswith theirpositions asper
320 Y. Furuse et al. / Virology 405 (2010) 314–321acids in sites are reported elsewhere (Gerhard et al., 1981; Stevens
et al., 2004).
Acknowledgments
This work was supported by the Health and Labor Science
Research Grants from the Ministry of Health, Labor, and Welfare,
Japan. We are indebted to the medical practitioners Dr. Makoto Shoji,
Dr. Kazuhisa Kawamura, Dr. Jun Kayaba, Dr. Syunzo Hayamizu, Dr.
Masataka Itano, and Dr. Kikuya Metoki in Sendai, Japan, for collecting
clinical specimens. YF is a recipient of a scholarship through the Honjo
International Scholarship Foundation.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.virol.2010.06.018.
References
Anisimova, M., Gascuel, O., 2006. Approximate likelihood-ratio test for branches: a fast,
accurate, and powerful alternative. Syst. Biol. 55 (4), 539–552.
Bao, Y., Bolotov, P., Dernovoy, D., Kiryutin, B., Zaslavsky, L., Tatusova, T., Ostell, J.,
Lipman, D., 2008. The inﬂuenza virus resource at the National Center for
Biotechnology Information. J. Virol. 82 (2), 596–601.
Campo, D.S., Dimitrova, Z., Mitchell, R.J., Lara, J., Khudyakov, Y., 2008. Coordinated
evolution of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 105 (28),
9685–9690.
Childs, R.A., Palma, A.S., Wharton, S., Matrosovich, T., Liu, Y., Chai, W., Campanero-Rhodes,
M.A., Zhang, Y., Eickmann, M., Kiso, M., Hay, A., Matrosovich, M., Feizi, T., 2009.
Receptor-binding speciﬁcity of pandemic inﬂuenza A (H1N1) 2009 virus determined
by carbohydrate microarray. Nat. Biotechnol. 27 (9), 797–799.
de Jong, J.C., Smith, D.J., Lapedes, A.S., Donatelli, I., Campitelli, L., Barigazzi, G., Van Reeth,
K., Jones, T.C., Rimmelzwaan, G.F., Osterhaus, A.D., Fouchier, R.A., 2007. Antigenic
and genetic evolution of swine inﬂuenza A (H3N2) viruses in Europe. J. Virol. 81
(8), 4315–4322.
Earp, L.J., Delos, S.E., Park, H.E., White, J.M., 2005. The many mechanisms of viral
membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285, 25–66.
Fitch,W.M., Bush, R.M., Bender, C.A., Cox, N.J., 1997. Long term trends in the evolution of
H(3) HA1 human inﬂuenza type A. Proc. Natl. Acad. Sci. USA 94 (15), 7712–7718.
Furuse, Y., Suzuki, A., Kamigaki, T., Oshitani, H., 2009. Evolution of the M gene of the
inﬂuenza A virus in different host species: Large-scale sequence analysis. Virol. J. 6
(1), 67.
Furuse, Y., Suzuki, A., Oshitani, H., 2010. Reassortment between swine inﬂuenza A
viruses increased their adaptation to humans in pandemic H1N1/09. Infect. Genet.
Evol.
Gambaryan, A.S., Robertson, J.S., Matrosovich, M.N., 1999. Effects of egg-adaptation on
the receptor-binding properties of human inﬂuenza A and B viruses. Virology 258
(2), 232–239.
Gamblin, S.J., Haire, L.F., Russell, R.J., Stevens, D.J., Xiao, B., Ha, Y., Vasisht, N., Steinhauer,
D.A., Daniels, R.S., Elliot, A., Wiley, D.C., Skehel, J.J., 2004. The structure and receptor
binding properties of the 1918 inﬂuenza hemagglutinin. Science 303 (5665),
1838–1842.
Garten, R.J., Davis, C.T., Russell, C.A., Shu, B., Lindstrom, S., Balish, A., Sessions, W.M., Xu,
X., Skepner, E., Deyde, V., Okomo-Adhiambo, M., Gubareva, L., Barnes, J., Smith, C.B.,
Emery, S.L., Hillman, M.J., Rivailler, P., Smagala, J., de Graaf, M., Burke, D.F., Fouchier,
R.A., Pappas, C., Alpuche-Aranda, C.M., Lopez-Gatell, H., Olivera, H., Lopez, I., Myers,
C.A., Faix, D., Blair, P.J., Yu, C., Keene, K.M., Dotson Jr., P.D., Boxrud, D., Sambol, A.R.,
Abid, S.H., St George, K., Bannerman, T., Moore, A.L., Stringer, D.J., Blevins, P.,
Demmler-Harrison, G.J., Ginsberg, M., Kriner, P., Waterman, S., Smole, S., Guevara,
H.F., Belongia, E.A., Clark, P.A., Beatrice, S.T., Donis, R., Katz, J., Finelli, L., Bridges, C.B.,
Shaw, M., Jernigan, D.B., Uyeki, T.M., Smith, D.J., Klimov, A.I., Cox, N.J., 2009.
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) inﬂuenza
viruses circulating in humans. Science 325 (5937), 197–201.
Gerhard, W., Yewdell, J., Frankel, M.E., Webster, R., 1981. Antigenic structure of
inﬂuenza virus haemagglutinin deﬁned by hybridoma antibodies. Nature 290
(5808), 713–717.
Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E.N., Sun, H., Liu, F., Dong, L., DeVos, J.
R., Gargiullo, P.M., Brammer, T.L., Cox, N.J., Tumpey, T.M., Katz, J.M., 2009. Cross-
reactive antibody responses to the 2009 pandemic H1N1 inﬂuenza virus. N. Engl. J.
Med. 361 (20), 1945–1952.
Hay, A.J., Gregory, V., Douglas, A.R., Lin, Y.P., 2001. The evolution of human inﬂuenza
viruses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (1416), 1861–1870.
Health Protection Agency, 2009. Composition of the Inﬂuenza Vaccine.
Hensley, S.E., Das, S.R., Bailey, A.L., Schmidt, L.M., Hickman, H.D., Jayaraman, A.,
Viswanathan, K., Raman, R., Sasisekharan, R., Bennink, J.R., Yewdell, J.W., 2009.
Hemagglutinin receptor binding avidity drives inﬂuenza A virus antigenic drift.
Science 326 (5953), 734–736.Hoffmann, E., Stech, J., Guan, Y., Webster, R.G., Perez, D.R., 2001. Universal primer set for
the full-length ampliﬁcation of all inﬂuenza A viruses. Arch. Virol. 146 (12),
2275–2289.
Igarashi, M., Ito, K., Kida, H., Takada, A., 2008. Genetically destinedpotentials forN-linked
glycosylation of inﬂuenza virus hemagglutinin. Virology 376 (2), 323–329.
Igarashi, M., Ito, K., Yoshida, R., Tomabechi, D., Kida, H., Takada, A., 2010. Predicting the
antigenic structure of the pandemic (H1N1) 2009 inﬂuenza virus hemagglutinin.
PLoS ONE 5 (1), e8553.
Inoue, E., Wang, X., Osawa, Y., Okazaki, K., 2010. Full genomic ampliﬁcation and
subtyping of inﬂuenza A virus using a single set of universal primers. Microbiol.
Immunol. 54 (3), 129–134.
Ito, T., Couceiro, J.N., Kelm, S., Baum, L.G., Krauss, S., Castrucci, M.R., Donatelli, I., Kida, H.,
Paulson, J.C., Webster, R.G., Kawaoka, Y., 1998. Molecular basis for the generation in
pigs of inﬂuenza A viruses with pandemic potential. J. Virol. 72 (9), 7367–7373.
Itoh, Y., Shinya, K., Kiso, M., Watanabe, T., Sakoda, Y., Hatta, M., Muramoto, Y., Tamura,
D., Sakai-Tagawa, Y., Noda, T., Sakabe, S., Imai, M., Hatta, Y., Watanabe, S., Li, C.,
Yamada, S., Fujii, K., Murakami, S., Imai, H., Kakugawa, S., Ito, M., Takano, R.,
Iwatsuki-Horimoto, K., Shimojima, M., Horimoto, T., Goto, H., Takahashi, K., Makino,
A., Ishigaki, H., Nakayama, M., Okamatsu, M., Warshauer, D., Shult, P.A., Saito, R.,
Suzuki, H., Furuta, Y., Yamashita, M., Mitamura, K., Nakano, K., Nakamura, M.,
Brockman-Schneider, R., Mitamura, H., Yamazaki, M., Sugaya, N., Suresh, M., Ozawa,
M., Neumann, G., Gern, J., Kida, H., Ogasawara, K., Kawaoka, Y., 2009. In vitro and in
vivo characterization of new swine-origin H1N1 inﬂuenza viruses. Nature 460
(7258), 1021–1025.
Kida, H., Ito, T., Yasuda, J., Shimizu, Y., Itakura, C., Shortridge, K.F., Kawaoka, Y., Webster,
R.G., 1994. Potential for transmission of avian inﬂuenza viruses to pigs. J. Gen. Virol.
75 (Pt 9), 2183–2188.
Kilbourne, E.D., Smith, C., Brett, I., Pokorny, B.A., Johansson, B., Cox, N., 2002. The total
inﬂuenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change
can explain failure of vaccine in a post-World War II epidemic. Proc. Natl. Acad. Sci.
U S A 99 (16), 10748–10752.
Kobasa, D., Takada, A., Shinya, K., Hatta, M., Halfmann, P., Theriault, S., Suzuki, H.,
Nishimura, H., Mitamura, K., Sugaya, N., Usui, T., Murata, T., Maeda, Y., Watanabe, S.,
Suresh, M., Suzuki, T., Suzuki, Y., Feldmann, H., Kawaoka, Y., 2004. Enhanced
virulence of inﬂuenza A viruses with the haemagglutinin of the 1918 pandemic
virus. Nature 431 (7009), 703–707.
Kosakovsky Pond, S.L., Frost, S.D.W., 2005. Not so different after all: a comparison ofmethods
for detecting amino acid sites under selection. Mol. Biol. Evol. 22 (5), 1208–1222.
Kumar, S., Nei, M., Dudley, J., Tamura, K., 2008. MEGA: a biologist-centric software for
evolutionary analysis of DNA and protein sequences. Brief. Bioinform. 9 (4), 299–306.
Matrosovich, M., Tuzikov, A., Bovin, N., Gambaryan, A., Klimov, A., Castrucci, M.R.,
Donatelli, I., Kawaoka, Y., 2000. Early alterations of the receptor-binding properties
of H1, H2, and H3 avian inﬂuenza virus hemagglutinins after their introduction into
mammals. J. Virol. 74 (18), 8502–8512.
Mehle, A., Doudna, J.A., 2009. Adaptive strategies of the inﬂuenza virus polymerase for
replication in humans. Proc. Natl. Acad. Sci. U S A 106 (50), 21312–21316.
Nobusawa, E., Aoyama, T., Kato, H., Suzuki, Y., Tateno, Y., Nakajima, K., 1991. Comparison of
complete amino acid sequences and receptor-binding properties among 13 serotypes
of hemagglutinins of inﬂuenza A viruses. Virology 182 (2), 475–485.
Pond, S.L.K., Frost, S.D.W., Grossman, Z., Gravenor, M.B., Richman, D.D., Brown, A.J.L.,
2006. Adaptation to different human populations by HIV-1 revealed by codon-
based analyses. PLoS Comput. Biol. 2 (6), e62.
Pond, S. L. K., Poon, A. F. Y., and Frost, S. D. W. (2007). Estimating selection pressures on
alignments of coding sequences. Analyses using HyPhy, Vol. 2008.
Raymond, F.L., Caton, A.J., Cox, N.J., Kendal, A.P., Brownlee, G.G., 1986. The antigenicity
and evolution of inﬂuenza H1 haemagglutinin, from 1950–1957 and 1977–1983:
two pathways from one gene. Virology 148 (2), 275–287.
Reid, A.H., Janczewski, T.A., Lourens, R.M., Elliot, A.J., Daniels, R.S., Berry, C.L., Oxford, J.S.,
Taubenberger, J.K., 2003. 1918 inﬂuenza pandemic caused by highly conserved
viruses with two receptor-binding variants. Emerg. Infect. Dis. 9 (10),
1249–1253.
Robertson, J.S., Bootman, J.S., Newman, R., Oxford, J.S., Daniels, R.S., Webster, R.G.,
Schild, G.C., 1987. Structural changes in the haemagglutinin which accompany egg
adaptation of an inﬂuenza A(H1N1) virus. Virology 160 (1), 31–37.
Rogers, G.N., Paulson, J.C., 1983. Receptor determinants of human and animal inﬂuenza
virus isolates: differences in receptor speciﬁcity of the H3 hemagglutinin based on
species of origin. Virology 127 (2), 361–373.
Schulze, I.T., 1997. Effects of glycosylation on the properties and functions of inﬂuenza
virus hemagglutinin. J. Infect. Dis. 176 (Suppl 1), S24–S28.
Shen, J., Ma, J., Wang, Q., 2009. Evolutionary trends of A(H1N1) inﬂuenza virus
hemagglutinin since 1918. PLoS ONE 4 (11), e7789.
Skehel, J.J., Wiley, D.C., 2000. Receptor binding andmembrane fusion in virus entry: the
inﬂuenza hemagglutinin. Annu. Rev. Biochem. 69, 531–569.
Smith, G.J.D., Vijaykrishna, D., Bahl, J., Lycett, S.J., Worobey, M., Pybus, O.G., Ma, S.K.,
Cheung, C.L., Raghwani, J., Bhatt, S., Peiris, J.S.M., Guan, Y., Rambaut, A., 2009.
Origins and evolutionary genomics of the 2009 swine-origin H1N1 inﬂuenza A
epidemic. Nature 459 (7250), 1122–1125.
Steinhauer, D.A., 1999. Role of hemagglutinin cleavage for the pathogenicity of
inﬂuenza virus. Virology 258 (1), 1–20.
Stevens, J., Corper, A.L., Basler, C.F., Taubenberger, J.K., Palese, P., Wilson, I.A., 2004.
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918
inﬂuenza virus. Science 303 (5665), 1866–1870.
Stevens, J., Blixt, O., Glaser, L., Taubenberger, J.K., Palese, P., Paulson, J.C., Wilson, I.A.,
2006. Glycan microarray analysis of the hemagglutinins from modern and
pandemic inﬂuenza viruses reveals different receptor speciﬁcities. J. Mol. Biol.
355 (5), 1143–1155.
321Y. Furuse et al. / Virology 405 (2010) 314–321Sugita, S., Yoshioka, Y., Itamura, S., Kanegae, Y., Oguchi, K., Gojobori, T., Nerome, K., Oya,
A., 1991. Molecular evolution of hemagglutinin genes of H1N1 swine and human
inﬂuenza A viruses. J. Mol. Evol. 32 (1), 16–23.
Suzuki, Y., 2006. Natural selection on the inﬂuenza virus genome. Mol. Biol. Evol. 23
(10), 1902–1911.
Suzuki, Y., 2008. Positive selection operates continuously on hemagglutinin during
evolution of H3N2 human inﬂuenza A virus. Gene 427 (1–2), 111–116.
Suzuki, Y., Gojobori, T., 1999. A method for detecting positive selection at single amino
acid sites. Mol. Biol. Evol. 16 (10), 1315–1328.
The World Health Organizaion, 2010. Pandemic (H1N1) 2009 — update 82, Vol. 2010.
Tumpey, T.M., Garcia-Sastre, A., Taubenberger, J.K., Palese, P., Swayne, D.E., Basler, C.F.,
2004. Pathogenicity and immunogenicity of inﬂuenza viruses with genes from the
1918 pandemic virus. Proc. Natl. Acad. Sci. U S A 101 (9), 3166–3171.
Tumpey, T.M., Maines, T.R., Van Hoeven, N., Glaser, L., Solorzano, A., Pappas, C., Cox, N.J.,
Swayne, D.E., Palese, P., Katz, J.M., Garcia-Sastre, A., 2007. A two-amino acid changein the hemagglutinin of the 1918 inﬂuenza virus abolishes transmission. Science
315 (5812), 655–659.
Webster, R.G., Bean, W.J., Gorman, O.T., Chambers, T.M., Kawaoka, Y., 1992. Evolution
and ecology of inﬂuenza A viruses. Microbiol. Rev. 56 (1), 152–179.
Wei, C.J., Boyington, J.C., Dai, K., Houser, K.V., Pearce, M.B., Kong, W.P., Yang, Z.Y., Tumpey,
T.M., Nabel, G.J., 2010. Cross-neutralization of 1918 and 2009 inﬂuenza viruses: role of
glycans in viral evolution and vaccine design. Sci. Transl. Med. 2 (24), 24ra21.
Xu, X., Rocha, E.P., Regenery, H.L., Kendal, A.P., Cox, N.J., 1993. Genetic and antigenic
analyses of inﬂuenza A (H1N1) viruses, 1986–1991. Virus Res. 28 (1), 37–55.
Yang, H., Carney, P., Stevens, J., 2010. Structure and receptor binding properties of a
pandemic H1N1 virus hemagglutinin. PLoS Curr. Inﬂuenza RRN1152.
Zhirnov, O.P., Vorobjeva, I.V., Saphonova, O.A., Poyarkov, S.V., Ovcharenko, A.V., Anhlan,
D., Malyshev, N.A., 2009. Structural and evolutionary characteristics of HA, NA, NS
and M genes of clinical inﬂuenza A/H3N2 viruses passaged in human and canine
cells. J. Clin. Virol. 45 (4), 322–333.
